Literature DB >> 32602416

Combined radiation strategies for novel and enhanced cancer treatment.

Georgios Kareliotis1, Ioanna Tremi1, Myrsini Kaitatzi1, Eleni Drakaki1, Alexandros A Serafetinides1, Mersini Makropoulou1, Alexandros G Georgakilas1.   

Abstract

Numerous studies focus on cancer therapy worldwide, and although many advances have been recorded, the complexity of the disease dictates thinking out of the box to confront it. This study reviews some of the currently available ionizing (IR) and non-ionizing radiation (NIR)-based treatment methods and explores their possible combinations that lead to synergistic, multimodal approaches with promising therapeutic outcomes. Traditional techniques, like radiotherapy (RT) show decent results, although they cannot spare 100% the healthy tissues neighboring with the cancer ones. Targeted therapies, such as proton and photodynamic therapy (PT and PDT, respectively) present adequate outcomes, even though each one has its own drawbacks. To overcome these limitations, the combination of therapeutic modalities has been proposed and has already been showing promising results. At the same time, the recent advances in nanotechnology in the form of nanoparticles enhance cancer therapy, making multimodal treatments worthy of exploring and studying. The combination of RT and PDT has reached the level of clinical trials and is showing promising results. Moreover, in vitro and in vivo studies of nanoparticles with PDT have also provided beneficial results concerning enhanced radiation treatments. In any case, novel and multimodal approaches have to be adopted to achieve personalized, enhanced and effective cancer treatment.

Entities:  

Keywords:  Multimodal treatment; NPs–PDT combination; RT–PDT combination; photodynamic therapy; proton–PDT combination

Year:  2020        PMID: 32602416     DOI: 10.1080/09553002.2020.1787544

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  8 in total

1.  Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy.

Authors:  Noor Nabilah Talik Sisin; Nor Fazila Che Mat; Raizulnasuha Ab Rashid; Norhayati Dollah; Khairunisak Abdul Razak; Moshi Geso; Merfat Algethami; Wan Nordiana Rahman
Journal:  Int J Nanomedicine       Date:  2022-09-02

2.  HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.

Authors:  Liana Mkrtchian; Irina Zamulaeva; Liudmila Krikunova; Valentina Kiseleva; Olga Matchuk; Liubov Liubina; Gunel Kulieva; Sergey Ivanov; Andrey Kaprin
Journal:  J Pers Med       Date:  2021-05-27

3.  Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment.

Authors:  Michael Rückert; Lisa Deloch; Benjamin Frey; Eberhard Schlücker; Rainer Fietkau; Udo S Gaipl
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

Review 4.  Multimodal targeting of glioma with functionalized nanoparticles.

Authors:  Hany E Marei
Journal:  Cancer Cell Int       Date:  2022-08-23       Impact factor: 6.429

Review 5.  MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.

Authors:  Xanthene Miles; Charlot Vandevoorde; Alistair Hunter; Julie Bolcaen
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

6.  Combining Augmented Radiotherapy and Immunotherapy through a Nano-Gold and Bacterial Outer-Membrane Vesicle Complex for the Treatment of Glioblastoma.

Authors:  Mei-Hsiu Chen; Tse-Ying Liu; Yu-Chiao Chen; Ming-Hong Chen
Journal:  Nanomaterials (Basel)       Date:  2021-06-24       Impact factor: 5.076

Review 7.  An Up-to-Date Review of Natural Nanoparticles for Cancer Management.

Authors:  Daniel Ion; Adelina-Gabriela Niculescu; Dan Nicolae Păduraru; Octavian Andronic; Florentina Mușat; Alexandru Mihai Grumezescu; Alexandra Bolocan
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321

Review 8.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.